Video

Glaucoma 360: Drug delivery contact lens technology

Author(s):

Alex Delaney-Gesing
Conferences|GLAUCOMA 360

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.


ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface diseases, during the 2020 Glaucoma 360 meeting in San Francisco, California.

See more Glaucoma 360 coverage here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
Related Content
MidWest Eye Center among first in Midwest to adopt new noncontact laser for glaucoma
July 15th 2025

MidWest Eye Center among first in Midwest to adopt new noncontact laser for glaucoma

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

RetinalGenix Technologies contracts LabCorp to support on DNA/RNA/GPS Pharmaco-Genetic Mapping platform
July 2nd 2025

RetinalGenix Technologies contracts LabCorp to support on DNA/RNA/GPS Pharmaco-Genetic Mapping platform

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Most patients support AI in health care if it means more time with doctors
June 30th 2025

Most patients support AI in health care if it means more time with doctors

Q&A: Sevgi Gurkan, MD, on the PER-001 for glaucoma and DR
June 28th 2025

Q&A: Sevgi Gurkan, MD, on the PER-001 for glaucoma and DR

© 2025 MJH Life Sciences

All rights reserved.